Transmission and progression to disease of mycobacterium tuberculosis phylogenetic lineages in the Netherlands

Journal of Clinical Microbiology

Volumn 53, Issue 10, 2015, Pages 3264-3271

  Nebenzahl Guimaraes, Hanna ^a,b,c   Verhagen, Lilly M ^d,e   Borgdorff, Martien W ^f,g   Van Soolingena, Dick ^e  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENOTYPE; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PHYLOGENY; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SPUTUM SMEAR; TUBERCULOSIS; ADOLESCENT; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; DISEASE TRANSMISSION; DNA FINGERPRINTING; GENETICS; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; MYCOBACTERIUM; NEWBORN; PHYLOGENY; PRESCHOOL CHILD; RISK ASSESSMENT; TRANSMISSION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DISEASE PROGRESSION; DISEASE TRANSMISSION, INFECTIOUS; DNA FINGERPRINTING; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR TYPING; MYCOBACTERIUM; NETHERLANDS; PHYLOGENY; RISK ASSESSMENT; TUBERCULOSIS; YOUNG ADULT;

EID: 84941975887     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01370-15     Document Type: Article

References (35)

1. Borgdorff MW, van den Hof S, Kremer K, Verhagen L, Kalisvaart N, Erkens C, van Soolingen D. 2010. Progress towards tuberculosis elimination: secular trend, immigration and transmission. Eur Respir J 36:339-347. http://dx. doi. org/10. 1183/09031936. 00155409.
2. Goguet de la Salmoniere YO, Li HM, Torrea G, Bunschoten A, van Embden J, Gicquel B. 1997. Evaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosis. J Clin Microbiol 35:2210-2214.
3. de Beer JL, van Ingen J, de Vries G, Erkens C, Sebek M, Mulder A, Sloot R, van den Brandt AM, Enaimi M, Kremer K, Supply P, van Soolingen D. 2013. Comparative study of IS6110 restriction fragment length polymorphism and variable-number tandem-repeat typing of Mycobacterium tuberculosis isolates in The Netherlands, based on a 5-year nationwide survey. J Clin Microbiol 51:1193-1198. http://dx. doi. org/10. 1128/JCM . 03061-12.
4. Kato-Maeda M, Gagneux S, Flores LL, Kim EY, Small PM, Desmond EP, Hopewell PC. 2011. Strain classification of Mycobacterium tuberculosis: congruence between large sequence polymorphisms and spoligotypes. Int J Tuberc Lung Dis 15:131-133.
5. Allix-Béguec C, Harmsen D, Weniger T, Supply P, Niemann S. 2008. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 46:2692-2699. http://dx. doi. org/10. 1128/JCM. 00540-08.
6. Kik SV, Verver S, van Soolingen D, de Haas PE, Cobelens FG, Kremer K, van Deutekom H, Borgdorff MW. 2008. Tuberculosis outbreaks predicted by characteristics of first patients in a DNA fingerprint cluster. Am J Respir Crit Care Med 178:96-104. http://dx. doi. org/10. 1164/rccm . 200708-1256OC.
7. Verhagen LM, van den Hof S, van Deutekom H, Hermans PW, Kremer K, Borgdorff MW, van Soolingen D. 2011. Mycobacterial factors relevant for transmission of tuberculosis. J Infect Dis 203:1249-1255. http://dx. doi . org/10. 1093/infdis/jir013.
8. Nebenzahl-Guimaraes H, Borgdorff MW, Murray MB, van Soolingen D. 2014. A novel approach: the propensity to propagate (PTP) method for controlling for host factors in studying the transmission of Mycobacterium tuberculosis. PLoS One 9:e97816. http://dx. doi. org/10. 1371/journal. pone . 0097816.
9. de Jong B, Hill PC, Aiken A, Awine T, Awine T, Antonio M, Adetifa IM, Jackson-Sillah DJ, Fox A, Deriemer K, Gagneux S, Borgdorff MW, McAdam KP, Corrah T, Small PM, Adegbola RA. 2008. Progression to active tuberculosis, but not transmission, varies by M. tuberculosis lineage in The Gambia. J Infect Dis 198:1037-1043. http://dx. doi. org/10. 1086 /591504.
10. Rhee JT, Piatek AS, Small PM, Harris LM, Chaparro SV, Kramer FR, Alland D. 1999. Molecular epidemiologic evaluation of transmissibility and virulence of Mycobacterium tuberculosis. J Clin Microbiol 37: 1764-1770.
11. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31:406-409.
12. Supply P, Allix C, Lesejean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D. 2006. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 44:4498-4510. http://dx. doi. org /10. 1128/JCM. 01392-06.
13. van Soolingen D, Borgdorff MW, de Haas PEW, Sebek MM, Veen J, Dessens M, Kremer K, van Embden JD. 1999. Molecular epidemiology of tuberculosis in The Netherlands: a nationwide study from 1993 through 1997. J Infect Dis 180:726-736. http://dx. doi. org/10. 1086/314930.
14. Weniger T, Krawczyk J, Supply P, Niemann S, Harmsen D. 2010. MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res 38:W326-3W31. http: //dx. doi. org/10. 1093/nar/gkq351.
15. Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR, Creasman JM, Schecter GF, Paz EA, Hopewell PC. 1999. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991 to 1997. Ann Intern Med 130:971-978. http://dx. doi. org/10. 7326/0003-4819-130-12-199906150-00004.
16. Mulder C, van Deutekom H, Huisman EM, Meijer-Veldman W, Erkens CG, van Rest J, Borgdorff MW, van Leth F. 2011. Coverage and yield of tuberculosis contact investigations in The Netherlands. Int J Tuberc Lung Dis 15:1630-1637. http://dx. doi. org/10. 5588/ijtld. 11. 0027.
17. Gehre F, Otu J, DeRiemer K, de Sessions PF, Hibberd ML, Mulders W, Corrah T, de Jong BC, Antonio M. 2014. Deciphering the growth behavior of Mycobacterium africanum. PLoS Negl Trop Dis 7:e2220. http: //dx. doi. org/10. 1371/journal. pntd. 0002220.
18. Albanna AS, Reed MB, Kotar KV, Fallow A, McIntosh FA, Behr MA, Menzies D. 2011. Reduced transmissibility of East African Indian strains of Mycobacterium tuberculosis. PLoS One 6:e25075. http://dx. doi. org/10 . 1371/journal. pone. 0025075.
19. Buu TN, Huyen MN, Lan NT, Quy HT, Hen NV, Zignol M, Borgdorff MW, Cobelens FG, van Soolingen D. 2009. The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam. Int J Tuberc Lung Dis 13:900-906.
20. Majoor CJ, Magis-Escurra C, van Ingen J, Boeree MJ, van Soolingen D. 2011. Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993 to 2007. Emerg Infect Dis 17:457-453. http://dx. doi. org/10 . 3201/eid1703. 101111.
21. Sunder S, Lanotte P, Godreuil S, Martin C, Boschiroli ML, Besnier JM. 2009. Human-to-human transmission of tuberculosis caused by Mycobacterium bovis in immunocompetent patients. J Clin Microbiol 47:1249-1251. http://dx. doi. org/10. 1128/JCM. 02042-08.
22. Etchechoury I, Valencia GE, Morcillo N, Sequeira MD, Imperiale B, López M, Caimi K, Zumarraga MJ, Cataldi A, Romano MI. 2010. Molecular typing of Mycobacterium bovis isolates in Argentina: first description of a person to person transmission case. Zoonoses Public Health 57:375-381. http://dx. doi. org/10. 1111/j. 1863-2378. 2009. 01233. x.
23. Yang C, Luo T, Sun G, Qiao K, Sun G, DeRiemer K, Mei J, Gao Q. 2012. Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in China. Clin Infect Dis 55:1179-1187. http://dx. doi. org/10 . 1093/cid/cis670.
24. Toungoussova OS, Mariandyshev A, Bjune G, Sandven P, Caugant DA. 2003. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin Infect Dis 37:665-672. http://dx. doi. org/10 . 1086/377205.
25. Langlois-Klassen D, Senthilselvan A, Chui L, Kunimoto D, Saunders LD, Menzies D, Long R. 2013. Transmission of Mycobacterium tuberculosis Beijing strains, Alberta, Canada, 1991 to 2007. Emerg Infect Dis 19: 701-711. http://dx. doi. org/10. 3201/eid1905. 121578.
26. Gagneux S, Small PM. 2007. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 7:328-337. http://dx. doi. org/10. 1016/S1473-3099(07)70108-1.
27. Lohmann EM, Koster BF, le Cessie S, Kamst-van Agterveld MP, van Soolingen D, Arend SM. 2012. Grading of a positive sputum smear and the risk of Mycobacterium tuberculosis transmission. Int J Tuberc Lung Dis 16:1477-1484. http://dx. doi. org/10. 5588/ijtld. 12. 0129.
28. Borgdorff MW, Nagelkerke NJD, de Haas PEW, van Soolingen D. 2001. Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases. Am J Epidemiol 154:934-943. http://dx. doi. org/10. 1093 /aje/154. 10. 934.
29. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, Enarson DA, Donald PR, Beyers N. 2004. The natural history of childhood intrathoracic tuberculosis: a critical review of literature from the prechemotherapy era. Int J Tuberc Lung Dis 8:392-402.
30. Wallinga J, Teunis P, Kretzschmar M. 2006. Using data on social contacts to estimate age-specific transmission parameters for respiratoryspread infectious agents. Am J Epidemiol 164:936-944. http://dx. doi. org /10. 1093/aje/kwj317.
31. Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. 2008. Alcohol use as a risk factor for tuberculosis: a systematic review. BMC Public Health 8:http://dx. doi. org/10. 1186/1471-2458-8-289.
32. Szabo G. 1997. Alcohol's contribution to compromised immunity. 1997. Alcohol Health Res World 21:30-38.
33. Carballo-Diéguez A, Sahs J, Goetz R, el Sadr W, Sorell S, Gorman J. 1994. The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users. Am J Drug Alcohol Abuse 20:317-329. http://dx. doi. org/10. 3109/00952999409106017.
34. Alonzo NC, Bayer BM. 2002. Opioids, immunology, and host defenses of intravenous drug abusers. Infect Dis Clin NorthAm16:553-569. http://dx . doi. org/10. 1016/S0891-5520(02)00018-1.
35. Portevin D, Gagneux S, Comas I, Young D. 2011. Human Macrophage Responses to Clinical Isolates from the Mycobacterium tuberculosis Complex Discriminate between Ancient and Modern Lineages. PLoS Pathog 7:e1001307. http://dx. doi. org/10. 1371/journal. ppat. 1001307.